Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba’s technology is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, asthma/COPD and acute lung injury.

Research Grants 1 show all


$265.3K
2006

Patents 102show all

  • 81
    A61K - Preparations for medical, dental, or toilet purposes
  • 30
    C07K - Peptides
  • 10
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1
    C07C - Acyclic or carbocyclic compounds

Clinical Trials 6show all

3Phase 22Phase 11N/A

SEC Filings show all


1
D

Contact Information

100 International Drive 23rd Floor
Baltimore, MD 21202
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$30,000,0001-102005-08-23Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2005-08-23$30,000,000Series ASV Health Investors, Alta PartnersRed Abbey Venture Partners, HealthCap, Maryland Venture Fund

SEC Form D Funding Events

DateOfferedSoldType
2005-09-07Unknown Unknown Other (Paper Filing)